E. Tasçi Et Al. , "Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study," vol.40, 0
Tasçi, E. Et Al. Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study. .
Tasçi, E., Oyan, B., Sonmez, O., Mutlu, A., Atci, M., Oner, I., ... Cinkir, H. Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study .
Tasçi, ES Et Al. "Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study,"
Tasçi, ES Et Al. "Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study."
Tasçi, E. Et Al. . "Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study." .
@conferencepaper{conferencepaper, author={ES Tasçi Et Al. }, title={Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study}, congress name={}, city={}, country={}, year={0}}